My watch list  

300 Current news of Merck


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Merck Reports Strong Third Quarter

In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion


Merck grew significantly in the third quarter. In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion. The increase was primarily due to double-digit percentage organic growth in the Life Science business sector and acquisition-related increases in the ...


image description
Merck Announces € 20 Million OLED Manufacturing Expansion in Korea and China

Additional OLED sublimation units will help meet customer demand in the growing OLED market of Asia


Merck announced a € 20 million expansion of its OLED (organic light-emitting diode) manufacturing capacity at its sites in Pyeongtaek, Korea and Shanghai, China. Additional sublimation units will be built to help meet customer demand in the growing OLED market. With the investment, Merck will ...


image description
Merck: Stefan Oschmann to Hand Over Chair of Executive Board to Belén Garijo in 2021

Two internationally experienced managers to join Executive Board


Stefan Oschmann will hand over the Chair of the Executive Board of Merck to Belén Garijo in 2021. The Board of Partners of E.MerckKG has appointed Garijo as new Chair of the Executive Board and CEO of Merck effective May 1, 2021. She is currently Vice Chair of the Executive Board and Deputy CEO ...


image description
Merck Well-Positioned for Further Growth

From today’s perspective targeted smaller to medium-sized acquisitions after 2022 more likely than major transformative deals


Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the period ...


image description
Merck Remains on Course in a Challenging Environment

Healthcare and Performance Materials more strongly affected by the Covid-19 pandemic than Life Science


Merck registered the effects of the Covid-19 pandemic in all business sectors in the second quarter. Healthcare and Performance Materials were affected most strongly. In comparison with the year-earlier quarter, Group sales increased by 3.7% to € 4.1 billion. EBITDA pre, the Group’s most ...


image description
Changes in Merck Executive Board

Belén Garijo appointed Vice Chairman of the Executive Board and Deputy CEO


The Board of Partners of E.MerckKG appointed Belén Garijo as Vice Chairman of the Executive Board and Deputy CEO of Merck KGaA. She will maintain her current Executive Board responsibilities. “The appointment of Belén Garijo as Vice Chairman of the Executive Board and Deputy CEO recognizes her ...


image description
Printed electronics to monitor industrial production processes

Startup from Merck Innovation Lab in Israel Markets First Predictive Maintenance Sensors


Merck announced the first commercial product from Feelit, based in Haifa, Israel. Feelit is an Industry 4.0 startup that was part of the Merck PMatX innovation lab for next-generation electronics in Israel. RetroFeel™, the company’s first product, combines a wireless edge device and a printed ...


image description
Merck Invests in Artificial Intelligence Chip Startup SynSense in China

Neuromorphic computing considered as key enabler of next-generation artificial intelligence


Merck announced its investment in SynSense (formerly known as aiCTX), a neuromorphic computing startup based in China and Switzerland. The startup’s AI (artificial intelligence) processors and sensors provide an unprecedented combination of ultra-low power consumption and low latency for a broad ...


Merck Meets all Financial Targets and Makes Significant Strategic Progress


Merck met all its financial targets and thus grew profitably in fiscal 2019. At the same time, Merck also made significant progress in executing its strategic agenda. “We delivered on our promise and achieved growth for all our key performance indicators, namely net sales, EBITDA pre and EPS pre. ...


Merck Generates Profitable Growth in Q3 2019


Merck generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019. EBITDA pre increased even more strongly than net sales in the three-month period from July to September. Following the closing of the Versum Materials (Versum) ...


Page 1 From 30
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE